Who
Mitchell Shuster Steiner
President and CEO
Company insider
Files Form 4 as: President and CEO, Veru; Chief Executive Officer, Gtx Inc /de/.
In numbers
- Trades disclosed
- 591
- Buys
- 16
- Sells
- 108
- Bought
- $499K
- Sold
- $15.3M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 24 Feb 2006
- Last trade
- 4 May 2026
- Last filed
- 6 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 6 May 2026 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —604,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —604,000 at $0.00 | filing |
| 5 Dec 2025filed 9 Dec 2025 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 6 May 2025filed 8 May 2025 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —378,000 at $0.00 | filing |
| 24 May 2024filed 24 May 2024 | VERU VeruBiotechnology | SEC FORM 4 Sold | $78K63,379 at $1.23 | filing |
| 23 May 2024filed 24 May 2024 | VERU VeruBiotechnology | SEC FORM 4 Sold | $405300 at $1.35 | filing |
| 22 May 2024filed 24 May 2024 | VERU VeruBiotechnology | SEC FORM 4 Sold | $9,0416,504 at $1.39 | filing |
| 17 May 2024filed 17 May 2024 | VERU VeruBiotechnology | SEC FORM 4 Sold | $37K28,066 at $1.32 | filing |
| 16 May 2024filed 17 May 2024 | VERU VeruBiotechnology | SEC FORM 4 Sold | $84K59,788 at $1.41 | filing |
| 15 May 2024filed 17 May 2024 | VERU VeruBiotechnology | SEC FORM 4 Sold | $126K84,021 at $1.50 | filing |
| 7 May 2024filed 9 May 2024 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —376,000 at $0.00 | filing |
| 9 May 2023filed 11 May 2023 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —374,000 at $0.00 | filing |
| 2 Nov 2022filed 4 Nov 2022 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —372,000 at $0.00 | filing |
| 22 Apr 2022filed 25 Apr 2022 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 3 Nov 2021filed 5 Nov 2021 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —360,000 at $0.00 | filing |
| 12 Feb 2021filed 12 Feb 2021 | VERU VeruBiotechnology | SEC FORM 4 Sold | $418K20,000 at $20.88 | filing |
| 16 Dec 2020filed 18 Dec 2020 | VERU VeruBiotechnology | SEC FORM 4 Sold | $2.4M250,000 at $9.69 | filing |
| 13 Nov 2020filed 17 Nov 2020 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 13 Nov 2020filed 17 Nov 2020 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —360,000 at $0.00 | filing |
| 5 Dec 2019filed 6 Dec 2019 | VERU VeruBiotechnology | SEC FORM 4 Sold | $37K16,590 at $2.22 | filing |
The newest 500 lines are listed; the numbers count every line.
News
No headline names them, or the companies they trade most, lately.